CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biotec Pharmacon ASA Company Snapshot
Biotec Pharmacon ASA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biotec Pharmacon ASA with three other pharmaceutical manufacturers in Europe: Polyphor AG of Switzerland (2018 sales of 6.55 million Swiss Francs [US$6.61 million] of which 100% was Pharma Business), Onxeo SA of France (6.13 million Euro [US$6.79 million] of which 91% was Operating segment -Rest of the world), and Addex Therapeutics which is based in Switzerland (6.70 million Swiss Francs [US$6.76 million] of which 100% was Pharmaceuticals Manufacture).

Sales Analysis. During the year ended December of 2018, sales at Biotec Pharmacon ASA were NOK 66.77 million (US$7.29 million). This is a very small increase of 0.1% versus 2017, when the company's sales were NOK 66.69 million. Despite this increase, sales are still below the level achieved in 2016, when Biotec Pharmacon ASA reported sales of NOK 71.90 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biotec Pharmacon ASA
  Stock Performance Chart for Biotec Pharmacon ASA
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 4.80
(Figures in Norwegian Kroner)
1 Week 1.3%   13 Weeks 9.3%  
4 Weeks 10.3%   52 Weeks 9.8%  
 
Biotec Pharmacon ASA Key Data:
  Ticker: BIOTEC Country: Norway
  Exchanges: OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 66,769,000
(Year Ending Jan 2019).
Employees: 43
  Currency: Norwegian Kroner Market Cap: 232,006,430
  Fiscal Yr Ends: December Shares Outstanding: 48,334,673
  Share Type: Ordinaere Aksje Closely Held Shares: 15,134,639
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.